Mesa Laboratories, Inc. (MLAB)
136.06
-6.17
(-4.34%)
USD |
NASDAQ |
Oct 06, 16:00
135.30
-0.76
(-0.56%)
Pre-Market: 08:58
Mesa Laboratories Gross Profit Margin (Quarterly) : 57.87% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 57.87% |
| March 31, 2026 | 59.46% |
| December 31, 2025 | 57.66% |
| September 30, 2025 | 54.30% |
| June 30, 2025 | 54.57% |
| March 31, 2025 | 52.08% |
| December 31, 2024 | 56.54% |
| September 30, 2024 | 54.60% |
| June 30, 2024 | 57.23% |
| March 31, 2024 | 52.76% |
| December 31, 2023 | 51.07% |
| September 30, 2023 | 50.18% |
| June 30, 2023 | 50.73% |
| March 31, 2023 | 49.75% |
| December 31, 2022 | 50.31% |
| September 30, 2022 | 52.72% |
| June 30, 2022 | 62.12% |
| March 31, 2022 | 44.77% |
| December 31, 2021 | 43.18% |
| September 30, 2021 | 54.08% |
| June 30, 2021 | 52.68% |
| March 31, 2021 | 55.10% |
| December 31, 2020 | 49.24% |
| September 30, 2020 | 55.78% |
| June 30, 2020 | 56.73% |
| Date | Value |
|---|---|
| March 31, 2020 | 50.85% |
| December 31, 2019 | 38.66% |
| September 30, 2019 | 54.54% |
| June 30, 2019 | 55.03% |
| March 31, 2019 | 52.72% |
| December 31, 2018 | 52.16% |
| September 30, 2018 | 51.22% |
| June 30, 2018 | 52.63% |
| March 31, 2018 | 53.96% |
| December 31, 2017 | 46.46% |
| September 30, 2017 | 50.85% |
| June 30, 2017 | 50.09% |
| March 31, 2017 | 50.89% |
| December 31, 2016 | 56.78% |
| September 30, 2016 | 56.23% |
| June 30, 2016 | 56.90% |
| March 31, 2016 | 54.70% |
| December 31, 2015 | 61.31% |
| September 30, 2015 | 53.17% |
| June 30, 2015 | 61.36% |
| March 31, 2015 | 62.03% |
| December 31, 2014 | 61.99% |
| September 30, 2014 | 59.99% |
| June 30, 2014 | 59.18% |
| March 31, 2014 | 61.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Lifecore Biomedical, Inc. | 35.34% |
| Repligen Corp. | 49.25% |
| Bio-Techne Corp. | 65.22% |
| Codexis, Inc. | 68.42% |
| MetaStat, Inc. | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 2.63% |
| Return on Assets | 1.12% |
| Return on Invested Capital | 1.35% |
| Profit Margin (Quarterly) | 4.71% |
| Operating Margin (Quarterly) | 11.69% |
| Return on Net Operating Assets | 1.25% |